Are you interested in bringing your academic discovery closer to clinical translation? Maybe you are being asked in your grant application to identify commercialization goals. Perhaps you have a really knowledgeable and keen team of scientists and clinicians encouraging you to advance a therapeutic product. In any of these scenarios you will need to obtain and spend investments wisely.
In this episode of Stem Cells from the Sofa, Patrick Bedford, Founder & Principal Consultant, weCANreg Consulting Group, Inc., will offer a high-level perspective of when, what, and how you can “Regulatory DIY” and when you should consider investing in regulatory expertise. In addition to offering some insights, SCN has coordinated with weCANreg Consulting Group Inc to make two simple and useful tools available to help you translate some of your research plans into regulatory plans. These tools will be available on the SCN website shortly after the presentation.
Patrick's talk is entitled, "Cell therapy development for academics: when, what and how to regulatory DIY"
Intended audience: scientists, trainees and research professionals.